Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06718842

Walking Program in Fatty Liver Children With Phenylketonuria

Walking Program in Fatty Liver Children With Phenylketonuria: Response of Liver Enzymes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
9 Years – 12 Years
Healthy volunteers
Not accepted

Summary

phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver

Detailed description

this study will include PKU children sufferers 9n=40) with non-alcoholic fatty liver to be randomly assigned to group I (n=20) that will perform walking program (online supervised free walking that will be applied daily for eight weeks) or group II (N=20) that will act as waitlisted children

Conditions

Interventions

TypeNameDescription
BEHAVIORALwalking free online supervised programthis Group I will include PKU children sufferers (n=20) with non-alcoholic fatty liver that will perform walking program (online supervised free walking that will be applied daily for eight weeks)

Timeline

Start date
2024-09-15
Primary completion
2025-01-30
Completion
2025-01-30
First posted
2024-12-05
Last updated
2024-12-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06718842. Inclusion in this directory is not an endorsement.